首页> 外文期刊>Research Journal of Medical Sciences >Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) Versus Conventional Oxygen Therapy for Treatment of Acute Cardiogenic Pulmonary Edema
【24h】

Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) Versus Conventional Oxygen Therapy for Treatment of Acute Cardiogenic Pulmonary Edema

机译:无创压力控制逆比通气(NIPCIRV)与常规氧气疗法治疗急性心源性肺水肿

获取原文
           

摘要

Previous studies suggesting the use of non-invasive ventilation modes in patients with Acute Cardiogenic Pulmonary Edema (ACPE). However, there are controversies regarding the benefit of using non-invasive ventilation in patients with ACPE. This study investigated the short-term effects of non Invasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) on respiratory, homodynamic and oxygenation parameters in patients with acute respiratory failure due to Acute Cardiogenic Pulmonary Edema (ACPE). Moreover, intubation need and the duration of Cardiac Care Unit (CCU) stay in those patients were investigated.In this randomized clinical trial study, 120 patients were assigned conventional oxygen therapy or NIPCIRV by a standard ventilator through a face mask in addition to standardized pharmacological treatment. Physiological parameters were obtained at different time points (0, 15, 30 and 60 min) post NIPCIRV. The main end points were intubation, recorded recovery time (defined as oxygen saturation of 96% or more),respiratory rate <30 breaths/min) and duration of CCU stay.Endotracheal intubation was required in 2 (3.3%) of 60 assigned non NIPCIRV and in 12 (20%) of 60 assigned conventional therapy (p = 0.001). Recovery time was significantly shorter in the NIPCIRV group (48±8 h) compared with control group (96±12 h) (p<0.05). NIPCIRV led to a rapid improvement in oxygenation, respiratory rate, arterial PH, heart rate and blood pressure in the first hour (p = 0.0001 ) .There were significant differences in length of stay in coronary care unit, stay from (3±1 days) in NIPCIRV group vs (7±1) in control group (p = 0.0001). Hospital mortality was 17 patients (28.33%) in conventional group and 8 patients (13.33%) in NIPCIRV group (p<0.001). This study confirms that the non-invasive ventilation method of NIPCIRV is superior to conventional oxygen therapy.
机译:先前的研究建议在急性心源性肺水肿(ACPE)患者中使用无创通气模式。但是,在ACPE患者中使用无创通气的益处存在争议。这项研究调查了非侵入性压力控制反比通气(NIPCIRV)对急性心源性肺水肿(ACPE)导致的急性呼吸衰竭患者的呼吸,同动力和氧合参数的短期影响。此外,还研究了这些患者的插管需求和心脏护理单元(CCU)的停留时间。在这项随机临床试验研究中,除了标准药理学方法外,还通过标准呼吸机通过面罩为120例患者分配了常规氧疗或NIPCIRV治疗。在NIPCIRV后的不同时间点(0、15、30和60分钟)获得生理参数。主要终点为气管插管,记录的恢复时间(定义为氧饱和度96%或以上),呼吸频率<30呼吸/分钟)和CCU停留时间。在60例未分配的非气管插管中,有2例(3.3%)需要进行气管插管NIPCIRV和60种指定常规疗法中的12种(20%)(p = 0.001)。与对照组(96±12 h)相比,NIPCIRV组(48±8 h)的恢复时间明显缩短(p <0.05)。 NIPCIRV在头一个小时的氧合,呼吸频率,动脉PH,心率和血压迅速改善(p = 0.0001)。从(3±1天)开始,冠心病监护室的住院时间存在显着差异。 )(NIPCIRV组),对照组(7±1)(p = 0.0001)。常规组的住院死亡率为17例(28.33%),NIPCIRV组为8例(13.33%)(p <0.001)。这项研究证实,NIPCIRV的无创通气方法优于常规的氧疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号